SCHEMBL17156502

SCHEMBL17156502

CCC(C)C(C)=CC(C)=O

nearest known ligand 0.46

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.31
TDP1 Q9NUW8 2/20 0.31
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17156501 1.00 ALDH1A1 (0.31) ALDH1A1TDP1TSHR
SCHEMBL7558747 0.83 KDM4E (0.34) TSHR
SCHEMBL7558750 0.83 KDM4E (0.34) TSHR
SCHEMBL1783181 0.81 CHRM1 (0.36) TDP1TSHR
SCHEMBL1783184 0.81 CHRM1 (0.36) TDP1TSHR
SCHEMBL15482744 0.78 HCAR2 (0.37) ALDH1A1
SCHEMBL17468963 0.78
SCHEMBL11918288 0.76
SCHEMBL22664967 0.76
SCHEMBL15482599 0.76 NPSR1 (0.48) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2930179-B1 RUTHENIUM COMPLEX AND METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING RUTHENIUM-CONTAINING THIN FILM TOSOH CORP (JP) 2018-09-05 EP disclosed
US-9349601-B2 Ruthenium complex, method for producing same, and method for producing ruthenium-containing thin film TOSOH CORPORATION (JP) 2016-05-24 US disclosed
US-20150303063-A1 RUTHENIUM COMPLEX, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING RUTHENIUM-CONTAINING THIN FILM SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) 2015-10-22 US disclosed
EP-2930179-A1 RUTHENIUM COMPLEX AND METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING RUTHENIUM-CONTAINING THIN FILM Tosoh Corporation (JP) 2015-10-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150303063-A1 RUTHENIUM COMPLEX, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING RUTHENIUM-CONTAINING THIN FILM OR10J3, NOX5, CYB5R3 ALDH1A1 1519/4885TDP1 2022/4885TSHR 3668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.